The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Garren Hideki since 2022.
This trader's CIK number is 1854126.
At the time of last reporting, Garren Hideki was the Chief Medical Officer of Prothena Corp Public Ltd Co. (stock ticker symbol PRTA).
Also see all insider trading activities at Prothena Corp Public Ltd Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | PRTA | 0 | $0 | 28,000 | $1,722,301 | 28,000 | $697,199 |
| 2022 | PRTA | 0 | $0 | 28,000 | $1,224,176 | 28,000 | $697,200 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | COYA | 4,000 | $0 | 0 | $0 | 0 | $0 |
1. Prothena Corp Public Ltd Co (PRTA)
2. Coya Therapeutics, Inc. (COYA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-16 | PRTA | Option Ex | 2,000 | 24.90 | 49,800 |
| 2023-08-16 | PRTA | Sale | 2,000 | 58.94 | 117,880 |
| 2023-07-12 | PRTA | Option Ex | 2,000 | 24.90 | 49,800 |
| 2023-07-12 | PRTA | Sale | 2,000 | 67.84 | 135,676 |
| 2023-06-16 | PRTA | Option Ex | 7,331 | 24.90 | 182,541 |
| 2023-06-16 | PRTA | Sale | 7,331 | 74.00 | 542,494 |
| 2023-06-14 | PRTA | Sale | 4,669 | 73.96 | 345,319 |
| 2023-06-14 | PRTA | Option Ex | 4,669 | 24.90 | 116,258 |
| 2023-03-15 | PRTA | Option Ex | 12,000 | 24.90 | 298,800 |
| 2023-03-15 | PRTA | Sale | 12,000 | 48.41 | 580,932 |
| 2022-12-01 | PRTA | Sale | 4,000 | 62.51 | 250,040 |
| 2022-12-01 | PRTA | Option Ex | 4,000 | 24.90 | 99,600 |
| 2022-11-01 | PRTA | Option Ex | 4,000 | 24.90 | 99,600 |
| 2022-11-01 | PRTA | Sale | 4,000 | 62.11 | 248,456 |
| 2022-10-03 | PRTA | Option Ex | 4,000 | 24.90 | 99,600 |
| 2022-10-03 | PRTA | Sale | 4,000 | 60.90 | 243,600 |
| 2022-09-15 | PRTA | Sale | 4,000 | 30.00 | 120,000 |
| 2022-09-15 | PRTA | Option Ex | 4,000 | 24.90 | 99,600 |
| 2022-08-01 | PRTA | Option Ex | 4,000 | 24.90 | 99,600 |
| 2022-08-01 | PRTA | Sale | 4,000 | 30.52 | 122,080 |
| 2022-07-06 | PRTA | Option Ex | 8,000 | 24.90 | 199,200 |
| 2022-07-06 | PRTA | Sale | 8,000 | 30.00 | 240,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-03 | COYA | Buy | 2,000 | .00 | 0 |
| 2023-01-03 | COYA | Buy | 2,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Garren Hideki (Chief Medical Officer of Prothena Corp Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.